Oligometastatic Hormone Sensitive Prostate Cancer
Oncology
Prevalence
256.0 / 100K
Incidence
111.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Oligometastatic Hormone Sensitive Prostate Cancer?
There are 1 clinical trial targeting Oligometastatic Hormone Sensitive Prostate Cancer tracked by BioSniper.
What is the prevalence of Oligometastatic Hormone Sensitive Prostate Cancer?
The estimated prevalence of Oligometastatic Hormone Sensitive Prostate Cancer is approximately 256.0 per 100,000 population.
Deep-dive into Oligometastatic Hormone Sensitive Prostate Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis